Search Browse Earnings

OnKure Therapeutics, Inc. — SlamSEC

OnKure Therapeutics, Inc.

Nasdaq:OKUR

Pharmaceutical Preparations·BOULDER, CO

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

FY 2024

Adj. EBITDA

-$36.5M

FY 2024

Net Income

-$35.3M

FY 2024

EPS (Diluted)

-$124.41

FY 2024

Stock Price

$3.59

+17.7%

2026-03-10

52W Range

$1.70 – $5.32

P/E Ratio

-0.0x

Market Cap

$120.0M

Cash

$29.9M

FY 2024

Total Debt

—

Net Cash

$29.9M

FY 2024

Enterprise Value

$90.1M

Debt / EBITDA

0.8x

FY 2024

EV / EBITDA

-2.5x

Employees

—